ISPE’s Drug Shortages Initiative focuses on the technical, scientific, manufacturing, quality and compliance issues associated with a company’s supply chain and related to its ability to source, manufacture and distribute products that have resulted in drug shortages.
Any effort to effectively address the complex and multi-faceted issues contributing to drug shortages requires close technical collaboration and clear communication between the pharmaceutical industry and global health authorities. For nearly a decade, ISPE has been instrumental in facilitating communication between the different sectors of the pharmaceutical industry and global health authorities related to drug shortages.
Guidance Documents
Active Pharmaceutical Ingredients (1)
+Drug Shortages (3)
+Project Management (1)
+Quality Assurance (1)
+Regulatory (2)
+Supply Chain Management (1)
+Community Discussions
Community Discussions
Pharmaceutical Engineering Magazine Articles
Webinars
Upcoming
On-Demand
Featured Conferences
